E

EBOS Group Ltd
OTC:EBOSY

Watchlist Manager
EBOS Group Ltd
OTC:EBOSY
Watchlist
Price: 41.94 USD Market Closed
Market Cap: 8.2B USD

Intrinsic Value

The intrinsic value of one EBOSY stock under the Base Case scenario is 34.06 USD. Compared to the current market price of 41.94 USD, EBOS Group Ltd is Overvalued by 19%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EBOSY Intrinsic Value
34.06 USD
Overvaluation 19%
Intrinsic Value
Price
E
Worst Case
Base Case
Best Case

Valuation History
EBOS Group Ltd

Valuation History Unavailable

Historical valuation for EBOSY cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Increasing pressure on government healthcare budgets in Australia and New Zealand could squeeze EBOS’s margins, as the company depends heavily on state-funded pharmaceutical distribution and reimbursement schemes.

Bull Theses

EBOS is positioned to capture rising healthcare demand driven by aging populations and growing chronic disease rates in Australia and New Zealand, which should fuel steady increases in prescription volumes and medical supply needs.

Show More Less
How do you feel about EBOSY?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about EBOS Group Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
EBOS Group Ltd

Current Assets 3B
Cash & Short-Term Investments 237.9m
Receivables 1.4B
Other Current Assets 1.3B
Non-Current Assets 3.9B
Long-Term Investments 97.3m
PP&E 859.2m
Intangibles 2.7B
Other Non-Current Assets 240.9m
Efficiency

Free Cash Flow Analysis
EBOS Group Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
EBOS Group Ltd

Revenue
12.6B AUD
Cost of Revenue
-11B AUD
Gross Profit
1.6B AUD
Operating Expenses
-1.2B AUD
Operating Income
456.9m AUD
Other Expenses
-211.1m AUD
Net Income
245.9m AUD
Fundamental Scores

EBOSY Profitability Score
Profitability Due Diligence

EBOS Group Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Positive 3-Years Revenue Growth
Positive Free Cash Flow
Positive 3-Year Average ROE
Positive Gross Profit
49/100
Profitability
Score

EBOS Group Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

EBOSY Solvency Score
Solvency Due Diligence

EBOS Group Ltd's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
41/100
Solvency
Score

EBOS Group Ltd's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EBOSY Price Targets Summary
EBOS Group Ltd

There are no price targets for EBOSY.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for EBOSY is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one EBOSY stock?

The intrinsic value of one EBOSY stock under the Base Case scenario is 34.06 USD.

Is EBOSY stock undervalued or overvalued?

Compared to the current market price of 41.94 USD, EBOS Group Ltd is Overvalued by 19%.

Back to Top